Hematology Clinical Account Specialist
CurrentCurrently launching the drug Epkinly (Epcoritumab) and promoting Imbruvica (Ibrutinib) in a the Los Angeles North territory which stretches from West Los Angeles to Santa Clara CountyField Based Trainer for the Southwest DivisionMember of Pharmacyclics EED&I Council (Equity, Equality, Diversity, and Inclusion)Pharmacyclics National Advisory Board